Search

Search Constraints

You searched for: Author/Creator Dent, Gersham

Search Results

1. Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial. Issue 3 (March 2023)

2. Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer‐assisted evaluation. Issue 5 (28th February 2022)

3. Concordance of CSF biomarkers with amyloid PET at baseline in EMERGE/ENGAGE, phase 3 studies of aducanumab in patients with early Alzheimer's disease. (20th December 2022)

4. Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer's disease: Developments in clinical trials and cognitive assessment. (7th December 2020)

5. Kinetics of myelin breakdown products: A labeling study in patients with progressive multiple sclerosis. Issue 3 (19th November 2021)

6. Reductions in biomarkers of Alzheimer's disease pathophysiology following treatment with aducanumab were associated with slowing in clinical decline. (1st February 2022)

7. Reductions in biomarkers of Alzheimer's disease pathophysiology following treatment with aducanumab were associated with slowing in clinical decline. (December 2021)